The Alberta Prion Research Institute is bringing the world's largest international prion research conference, PRION 2013, to the Canadian Rockies, May 26-29, 2013 in Banff, Alberta.
For more information, please visit the Prion 2013 website.
Since the first cases of 'mad cow disease' appeared in the 1980s, prion diseases have become a major world-wide public health concern, with important health and economic consequences.
This new website has been especially re-designed for videos and aims to:
- Explain to the general public what are prions and other related diseases,
- Present the NeuroPrion Network and its resources,
- Facilitate the partnerships with industrials and other research institutes.
This site is still under construction. Some sections are not complete yet. If you have any suggestions, please send an e-mail to the webmaster.
Prions are the first known transmissible agents that are not bacteria, viruses, fungi, or parasites, and are considered as pure proteins. These transmissible agents, which were initially thought to be unconventional viruses are now considered by most scientists to be devoid of genomic information (nucleic acids) .
Prions are responsible for degenerative brain diseases like Creutzfeldt-Jakob Disease (CJD) in humans, Bovine Spongiform Encephalopathy (Mad cow disease) in cattle, Scrapie in sheep and goats.
To learn more about prions, please go to the section "About Prions".
NeuroPrion is a European network of excellence funded by the European Union and dedicated to research on prion diseases. It includes 52 research institutes in 20 different countries and federates over 120 individual research groups representing more than 90% of prion public research teams in Europe and more than 50% worldwide.
The primary objectives of NeuroPrion are to integrate the efforts of the main European prion research teams in order to reduce the fragmentation and/or duplication of research and to establish a lasting approach that will protect and improve human and animal health.
To learn more about NeuroPrion, please go to the section "NeuroPrion".
NeuroPrion is open to international collaborations and partnerships. The network has built a first « NeuroPrion platform » next to Paris which aims to facilitate the formation of public/private partnerships and already welcome the Foundation Alliance BioSecure which sustains original prion research projects.
To learn more about partnerships and the NeuroPrion platforms, please go to the section "Collaborations".
Creutzfeldt-Jakob Disease (CJD) patients and their families need to have reliable information about new advances in research and treatment. Several organisations from all around the world bring together CJD patients in order to exchange their experiences and learn first hand from researchers working on prions.
To learn more about CJD Patient associations please go to the section "Patient Associations".